BioAge Net Interest Income from 2010 to 2026
| BIOA Stock | 20.15 0.24 1.21% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter 8.4 M | Current Value 8.8 M | Quarterly Volatility 3.5 M |
Check BioAge Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAge Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 142.8 K, Interest Expense of 3.6 M or Selling General Administrative of 23.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.18. BioAge financial statements analysis is a perfect complement when working with BioAge Labs Valuation or Volatility modules.
BioAge | Net Interest Income | Build AI portfolio with BioAge Stock |
Analyzing BioAge Labs's Net Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Interest Income has evolved provides context for assessing BioAge Labs's current valuation and future prospects.
Latest BioAge Labs' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of BioAge Labs over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. BioAge Labs' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioAge Labs' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
BioAge Net Interest Income Regression Statistics
| Arithmetic Mean | 1,290,069 | |
| Coefficient Of Variation | 274.40 | |
| Mean Deviation | 2,413,172 | |
| Median | 224,000 | |
| Standard Deviation | 3,539,908 | |
| Sample Variance | 12.5T | |
| Range | 14.1M | |
| R-Value | 0.49 | |
| Mean Square Error | 10.2T | |
| R-Squared | 0.24 | |
| Significance | 0.05 | |
| Slope | 342,017 | |
| Total Sum of Squares | 200.5T |
BioAge Net Interest Income History
About BioAge Labs Financial Statements
BioAge Labs stakeholders use historical fundamental indicators, such as BioAge Labs' Net Interest Income, to determine how well the company is positioned to perform in the future. Although BioAge Labs investors may analyze each financial statement separately, they are all interrelated. For example, changes in BioAge Labs' assets and liabilities are reflected in the revenues and expenses on BioAge Labs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BioAge Labs. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 8.4 M | 8.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BioAge Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioAge Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioage Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioage Labs Stock:Check out the analysis of BioAge Labs Correlation against competitors. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs. Projected growth potential of BioAge fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive BioAge Labs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate BioAge Labs using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BioAge Labs' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause BioAge Labs' market price to deviate significantly from intrinsic value.
It's important to distinguish between BioAge Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BioAge Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BioAge Labs' market price signifies the transaction level at which participants voluntarily complete trades.